Results 171 to 180 of about 2,314,861 (318)

Precautionary Recommendation System in Risk Management: A FMEA-Based Approach. [PDF]

Risk Manag Healthc Policy
Narlı M.
europepmc   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz, Josefine Eck, Joel S. Winston, Kate Baker   +3 more
wiley   +1 more source

Preface: ICFM9 – River Basin Disaster Resilience and Sustainability by All [PDF]

Proceedings of the International Association of Hydrological Sciences
T. Koike, S. Egashira, M. Ohara, M. Ohara, A. W. M. Rasmy, T. Ushiyama, M. Miyamoto, D. Harada, K. Naito, C. Cudennec, S. Fischer   +10 more
doaj   +1 more source

Implementing a suicide risk management protocol as part of a multisite clinical trial: Findings and lessons learned. [PDF]

Clin Trials
Chase E, Moreira N, Blanchard BE, Rouvere J, Ferro L, Bechtel JM, Moore DL, Vakoch D, Law KC, Unützer J, Fortney JC.   +10 more
europepmc   +1 more source

Enterprise Asset Management Risks and Management and Control Strategies [PDF]

openalex   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

Advancing risk management in nuclear medicine diagnostic and therapy through incident-driven risk management tools. [PDF]

Z Med Phys
Strigari L, Menichelli D, Rizzini EL, Golemi A, Sacchetti GM, Leva L, Nanni C, Castelucci P, Fanti S, Morganti AG, Matheoud R.   +10 more
europepmc   +1 more source

LAI Paper Series: “Lean Product Development for Practitioners”: Risk Management in Lean PD

, 2010
Josef Oehmen, Eric Rebentisch
openalex   +1 more source

Enhancing Data Integrity and Legal Accountability: A Blockchain-Driven Approach to Corporate Fraud Risk Management [PDF]

Victor Chinedu Achebe, Oluwatosin Ilori, Ngozi Joan Isibor   +2 more
openalex   +1 more source

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care.
Amin Mehrabian, Peter Auguste, Amy Grove, Anna Brown, Janette Parr, Mubarak Patel, Furqan Butt, Jeremiah Donoghue, Mehdi Yousefi, Jo Parsons   +9 more
wiley   +1 more source